Analysis of Ordaōs Announces Appointment of Ziwei Liang, PhD to Role of Chief Science Officer - aVenture Research
ordaos.bio
Ordaōs Announces Appointment of Ziwei Liang, PhD to Role of Chief Science Officer
NEW YORK, Dec. 15, 2022 /PRNewswire/ -- Ordaōs, a biotechnology company designing novel mini-proteins to help drug hunters deliver life-saving treatments, today announced that company co-founder Ziwei Liang, PhD, has been elevated to the role of Chief Science Officer for this emerging biotech company. In this position, Dr. Liang will drive the drug discovery strategy, manage the multiple research programs, and lead a team of machine learning and AI scientists to develop an internal in silico pip
An analysis reads this article and its sources, then explains what happened, who is involved, and what it means, quoting a source for each claim. Once written, every reader sees it here.
Analysis requires a paid plan or prepaid credits and uses your company research allowance.